In terms of treatment, previous studies have shown that ECT2 in cancer cells overcomes endogenous DNA damage by promoting double-strand break (DSB) repair to maintain their survival and reduce the effect of radiotherapy or chemotherapy (Liu et al., 2014). Here, ECT2 is linked to cancer.